FL: DEB025 is a cyclophilin inhibitor, not an NS5A inhibitor; because it targets a host protein rather than a viral protein, DEB025 can, in theory, be used in combination with any class of HCV drug (#msg-56880596, #msg-68707215, #msg-61671677, #msg-56835202).
Market Data 
Markets 
AI
